{"id": "267225", "url": "https://fevir.net/resources/Group/267225", "meta": {"versionId": "10", "lastUpdated": "2025-12-11T20:35:21.032Z"}, "name": "NCT03421379_Eligibility_Criteria", "title": "NCT03421379 Eligibility Criteria", "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "extension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-author", "valueContactDetail": {"name": "Computable Publishing\u00ae: ClinicalTrials.gov-to-FEvIR Converter"}}, {"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as", "valueMarkdown": "NCT03421379 Eligibility Criteria [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing\u00ae: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 267225. Revised 2025-12-11. Available at: https://fevir.net/resources/Group/267225. Computable resource at: https://fevir.net/resources/Group/267225#json."}], "publisher": "Computable Publishing LLC", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"code": "ACSN", "system": "http://terminology.hl7.org/CodeSystem/v2-0203", "display": "Accession ID"}]}, "value": "267225", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "FEvIR Linking Identifier"}, "value": "NCT03421379 Eligibility Criteria", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}], "membership": "conceptual", "description": "Inclusion Criteria:\n* Participants with Type 1 diabetes (T1D) or Type 2 diabetes (T2D)\n* Body mass Index (BMI) of 18.5 to 30.0 kilograms per meter squared (kg/m2) for T1D, or 18.5 to 35.0 kg/m2 for T2D\n* Hemoglobin A1c (HbA1c) \u226410%\nExclusion Criteria:\n* Have significant changes in insulin regimen and/ or unstable blood sugar control within the past 3 month\n* Have received a total daily dose of insulin \\>1.2 units per kilogram (U/kg)", "resourceType": "Group", "characteristic": [{"code": {"text": "Defined by CodeableConcept"}, "exclude": false, "valueCodeableConcept": {"text": "Participants with Type 1 diabetes (T1D) or Type 2 diabetes (T2D)"}}, {"code": {"text": "Defined by CodeableConcept"}, "exclude": false, "valueCodeableConcept": {"text": "Body mass Index (BMI) of 18.5 to 30.0 kilograms per meter squared (kg/m2) for T1D, or 18.5 to 35.0 kg/m2 for T2D"}}, {"code": {"text": "Defined by CodeableConcept"}, "exclude": false, "valueCodeableConcept": {"text": "Hemoglobin A1c (HbA1c) \u226410%"}}, {"code": {"text": "Defined by CodeableConcept"}, "exclude": true, "valueCodeableConcept": {"text": "Have significant changes in insulin regimen and/ or unstable blood sugar control within the past 3 month"}}, {"code": {"text": "Defined by CodeableConcept"}, "exclude": true, "valueCodeableConcept": {"text": "Have received a total daily dose of insulin \\>1.2 units per kilogram (U/kg)"}}], "combinationMethod": "all-of"}